Details of the Drug

General Information of Drug (ID: DMAAB9A)

Drug Name

Methylselenocysteine

Synonyms

Se-methylselenocysteine; 26046-90-2; (R)-2-Amino-3-(methylselanyl)propanoic acid; 3-(Methylseleno)-L-alanine; Se-Methyl-L-selenocysteine; L-Alanine, 3-(methylseleno)-; Selenium-methylselenocystine; Se-Methyl-seleno-L-cysteine; UNII-TWK220499Z; CHEBI:27812; TWK220499Z; Se-methylseleno-L-cysteine; Se-(Methyl)selenocysteine hydrochloride; (2R)-2-amino-3-methylselanylpropanoic acid; Se-methylseleno-L-cysteine, 98%; Selenomethylselenocysteine; CCRIS 5465; Selenomethyl selenocysteine; Methylseleno-L-cysteine; L-Se-methylselenocysteine; C4H9NO2Se; L-methylselenocysteine; methyl-L-selenocysteine; Cysteine, seleno-methyl-; Lopac0_000799; 3-(Methylselanyl)-L-alanine; CHEMBL62382; SCHEMBL420015; Se-(Methyl)seleno-L-cysteine; L-Selenomethylcysteine 0.5% Tr; 2218AB; ANW-64816; MFCD00800565; AKOS016005152; 2-Amino-3-methylselenyl propionic acid; CCG-204883; DB12697; SDCCGSBI-0050776.P002; NCGC00162258-01; NCGC00162258-02; HY-114245; CS-0080570; (2R)-2-amino-3-(methylselanyl)propanoic acid; C05689; J-016235; Q21099600

Indication

Disease Entry	ICD 11	Status	REF
Breast cancer	2C60-2C65	Clinical Trial	[1]
Prostate cancer	2C82.0	Clinical Trial	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL is unavailable

2D MOL

Chemical Identifiers

Formula: C4H9NO2Se
Canonical SMILES: C[Se]CC(C(=O)O)N
InChI: 1S/C4H9NO2Se/c1-8-2-3(5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m0/s1
InChIKey: XDSSPSLGNGIIHP-VKHMYHEASA-N

Cross-matching ID

PubChem CID: 147004
ChEBI ID: CHEBI:27812
CAS Number: 26046-90-2
TTD ID: D53CMU

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	ClinicalTrials.gov (NCT01611038) Methylselenocysteine Effects on Circadian Rhythm. U.S. National Institutes of Health.